Fred has extensive life sciences experience evaluating new technology opportunities from early stage development through marketed products. He started his career in the labs conducting basic research and then transitioned to market research, business analysis and licensing and business development. He has held senior level management positions at both small and large global life science companies (Phosphagenics, GeminX, Penwest, Novartis Oncology, Pharmacia Upjohn and Rhone Poulenc Rorer). Most recently, he has been consulting with small startups advising them in the areas of technology and valuation assessment of assets, as well as licensing.

Throughout his career, Fred has worked to develop new drugs and products through either collaborations or internal development. He has experience in the following therapeutic areas: antibacterial, anti-viral, oncology, cardiovascular, respiratory and CNS.